Page last updated: 2024-09-05

antalarmin and dmp 696

antalarmin has been researched along with dmp 696 in 4 studies

Compound Research Comparison

Studies
(antalarmin)
Trials
(antalarmin)
Recent Studies (post-2010)
(antalarmin)
Studies
(dmp 696)
Trials
(dmp 696)
Recent Studies (post-2010) (dmp 696)
1810763104

Protein Interaction Comparison

ProteinTaxonomyantalarmin (IC50)dmp 696 (IC50)
Histamine H1 receptorCavia porcellus (domestic guinea pig)0.0398
Corticotropin-releasing factor receptor 1Homo sapiens (human)0.0504
Corticotropin-releasing factor receptor 1Rattus norvegicus (Norway rat)0.0042

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilligan, PJ; Robertson, DW; Zaczek, R1
Chen, TK; Crowe, PD; Dyck, B; Grey, J; Grigoriadis, DE; Gross, RS; Guo, Z; Haddach, M; Kiankarimi, M; Lanier, M; Li, BF; Luo, Z; McCarthy, JR; Moorjani, M; Saunders, J; Sullivan, R; Tellew, JE; Williams, JP; Zamani-Kord, S; Zhang, X1
Crowe, PD; Grigoriadis, DE; Hoare, SR; Ling, N; Schwarz, DA; Sullivan, SK; Vale, WW1
Carey, GJ; Gold, LH; Nielsen, DM1

Reviews

1 review(s) available for antalarmin and dmp 696

ArticleYear
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents.
    Journal of medicinal chemistry, 2000, May-04, Volume: 43, Issue:9

    Topics: Amino Acid Sequence; Animals; Humans; Molecular Sequence Data; Receptors, Corticotropin-Releasing Hormone; Stress, Physiological

2000

Other Studies

3 other study(ies) available for antalarmin and dmp 696

ArticleYear
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists.
    Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16

    Topics: Administration, Oral; Adrenocorticotropic Hormone; Animals; Blood-Brain Barrier; CHO Cells; Corticotropin-Releasing Hormone; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Injections, Intravenous; Male; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stereoisomerism; Structure-Activity Relationship

2005
Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Biochemistry, 2004, Apr-06, Volume: 43, Issue:13

    Topics: Amphibian Proteins; Aniline Compounds; Animals; Binding, Competitive; Cell Line; Corticotropin-Releasing Hormone; Extracellular Space; GTP-Binding Proteins; Humans; Ligands; Models, Chemical; Peptide Fragments; Peptide Hormones; Peptides; Protein Binding; Protein Structure, Tertiary; Pyrazoles; Pyrimidines; Pyrroles; Rats; Receptors, Corticotropin-Releasing Hormone; Triazines; Urocortins

2004
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
    European journal of pharmacology, 2004, Sep-19, Volume: 499, Issue:1-2

    Topics: Animals; Antidepressive Agents; Clorgyline; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hindlimb Suspension; Male; Mice; Morpholines; Motor Activity; Paroxetine; Pyrazoles; Pyrimidines; Pyrroles; Reboxetine; Receptors, Corticotropin-Releasing Hormone; Selegiline; Swimming; Tranylcypromine; Triazines

2004